Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-005234
Filing Date
2022-01-19
Accepted
2022-01-19 11:05:34
Documents
2
Group Members
ALEX NOAH INVESTORS, INC.JONATHAN I. COPEJOSHUA B. SCHEINFELDLINCOLN PARK CAPITAL, LLCROCKLEDGE CAPITAL CORP

Document Format Files

Seq Description Document Type Size
1 SC 13G tm223799d1_sc13g.htm SC 13G 123942
2 EXHIBIT 1 tm223799d1_ex1.htm EX-99.1 15329
  Complete submission text file 0001104659-22-005234.txt   141098
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90199 | Film No.: 22537306
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 440 NORTH WELLS STREET SUITE 410 CHICAGO IL 60654
Business Address 440 NORTH WELLS STREET SUITE 410 CHICAGO IL 60654 312-822-9300
Lincoln Park Capital Fund, LLC (Filed by) CIK: 0001592644 (see all company filings)

EIN.: 010939472 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G